Articoli correlati a Design and Evaluation of Colon Specific Drug Delivery...

Design and Evaluation of Colon Specific Drug Delivery System: Formulation, optimization and evaluation of Colon Specific Drug Delivery System for Ulcerative Colitis - Brossura

 
9783844394825: Design and Evaluation of Colon Specific Drug Delivery System: Formulation, optimization and evaluation of Colon Specific Drug Delivery System for Ulcerative Colitis

Sinossi

Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the treatment of local diseases associated with the colon like Crohn’s diseases, ulcerative colitis, irritable bowl syndrome but also for the potential it holds for the systemic delivery of proteins and therapeutic peptides. Targeted drug delivery to the colon would therefore, ensure direct treatment at the disease site and, consequently, lower dosing and reducing systemic side effects. The most critical challenge in such drug delivery approach is to preserve the formulation during its passage through the stomach and about first six meters of small intestine. In the present investigations, two drugs mesalamine and budesonide was selected for ulcerative colitis in colon. An attempt was made to prepare formulations which could not release the drug into stomach for up to 2 h. which is residence time for it, also it could not release the drug into small intestine up to 3 h. which is residence time for it and could release the drug up to 24 h to 3 days which is residence time for colon. These attempts formulate the colon targeted controlled release dosage form for ulcerative colitis.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

L'autore

Dr. Nirav V. PatelM.Pharm, Ph.D. Assistant Professor Department of Pharmaceutics Anand Pharmacy College, AnandIndia.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Compra usato

Condizioni: come nuovo
Like New
Visualizza questo articolo

EUR 28,73 per la spedizione da Regno Unito a Italia

Destinazione, tempi e costi

EUR 9,70 per la spedizione da Germania a Italia

Destinazione, tempi e costi

Risultati della ricerca per Design and Evaluation of Colon Specific Drug Delivery...

Immagini fornite dal venditore

NIRAV PATEL|Dr. Jayvadan K Patel|Ali A. Ali
ISBN 10: 3844394826 ISBN 13: 9783844394825
Nuovo Brossura
Print on Demand

Da: moluna, Greven, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: PATEL NIRAVDr. Nirav V. PatelM.Pharm, Ph.D. Assistant Professor Department of Pharmaceutics Anand Pharmacy College, AnandIndia.Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the . Codice articolo 5476958

Contatta il venditore

Compra nuovo

EUR 63,42
Convertire valuta
Spese di spedizione: EUR 9,70
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Nirav Patel
ISBN 10: 3844394826 ISBN 13: 9783844394825
Nuovo Taschenbuch
Print on Demand

Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the treatment of local diseases associated with the colon like Crohn's diseases, ulcerative colitis, irritable bowl syndrome but also for the potential it holds for the systemic delivery of proteins and therapeutic peptides. Targeted drug delivery to the colon would therefore, ensure direct treatment at the disease site and, consequently, lower dosing and reducing systemic side effects. The most critical challenge in such drug delivery approach is to preserve the formulation during its passage through the stomach and about first six meters of small intestine. In the present investigations, two drugs mesalamine and budesonide was selected for ulcerative colitis in colon. An attempt was made to prepare formulations which could not release the drug into stomach for up to 2 h. which is residence time for it, also it could not release the drug into small intestine up to 3 h. which is residence time for it and could release the drug up to 24 h to 3 days which is residence time for colon. These attempts formulate the colon targeted controlled release dosage form for ulcerative colitis. 288 pp. Englisch. Codice articolo 9783844394825

Contatta il venditore

Compra nuovo

EUR 79,00
Convertire valuta
Spese di spedizione: EUR 11,00
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Nirav Patel
ISBN 10: 3844394826 ISBN 13: 9783844394825
Nuovo Taschenbuch
Print on Demand

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the treatment of local diseases associated with the colon like Crohn's diseases, ulcerative colitis, irritable bowl syndrome but also for the potential it holds for the systemic delivery of proteins and therapeutic peptides. Targeted drug delivery to the colon would therefore, ensure direct treatment at the disease site and, consequently, lower dosing and reducing systemic side effects. The most critical challenge in such drug delivery approach is to preserve the formulation during its passage through the stomach and about first six meters of small intestine. In the present investigations, two drugs mesalamine and budesonide was selected for ulcerative colitis in colon. An attempt was made to prepare formulations which could not release the drug into stomach for up to 2 h. which is residence time for it, also it could not release the drug into small intestine up to 3 h. which is residence time for it and could release the drug up to 24 h to 3 days which is residence time for colon. These attempts formulate the colon targeted controlled release dosage form for ulcerative colitis. Codice articolo 9783844394825

Contatta il venditore

Compra nuovo

EUR 79,00
Convertire valuta
Spese di spedizione: EUR 14,99
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Nirav Patel
ISBN 10: 3844394826 ISBN 13: 9783844394825
Nuovo Taschenbuch

Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. Neuware -Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the treatment of local diseases associated with the colon like Crohn¿s diseases, ulcerative colitis, irritable bowl syndrome but also for the potential it holds for the systemic delivery of proteins and therapeutic peptides. Targeted drug delivery to the colon would therefore, ensure direct treatment at the disease site and, consequently, lower dosing and reducing systemic side effects. The most critical challenge in such drug delivery approach is to preserve the formulation during its passage through the stomach and about first six meters of small intestine. In the present investigations, two drugs mesalamine and budesonide was selected for ulcerative colitis in colon. An attempt was made to prepare formulations which could not release the drug into stomach for up to 2 h. which is residence time for it, also it could not release the drug into small intestine up to 3 h. which is residence time for it and could release the drug up to 24 h to 3 days which is residence time for colon. These attempts formulate the colon targeted controlled release dosage form for ulcerative colitis.Books on Demand GmbH, Überseering 33, 22297 Hamburg 288 pp. Englisch. Codice articolo 9783844394825

Contatta il venditore

Compra nuovo

EUR 79,00
Convertire valuta
Spese di spedizione: EUR 15,00
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Foto dell'editore

PATEL, NIRAV, Jayvadan K Patel, Dr., A. Ali, Ali
ISBN 10: 3844394826 ISBN 13: 9783844394825
Antico o usato Paperback

Da: Mispah books, Redhill, SURRE, Regno Unito

Valutazione del venditore 4 su 5 stelle 4 stelle, Maggiori informazioni sulle valutazioni dei venditori

Paperback. Condizione: Like New. Like New. book. Codice articolo ERICA79638443948266

Contatta il venditore

Compra usato

EUR 150,33
Convertire valuta
Spese di spedizione: EUR 28,73
Da: Regno Unito a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello